Assembly Biosciences Inc

Assembly Biosciences Inc

ASMB - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$430.02M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Assembly Biosciences IncAssembly Biosciences Inc25.8--4%21.10.1
$51.67

Target Price by Analysts

144.6% upsideAssembly Biosciences Target Price DetailsTarget Price
$0.18

Current Fair Value

99.2% downside

Overvalued by 99.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$430.02 Million
Enterprise Value$416.89 Million
Earnings per Share$-0.55
Beta1.22
Outstanding Shares21,780,874

Return

Return on Equity-3.72%ROE
Return on Assets-3.41%
Return on Invested Capital-6.67%

Valuation & Multiples

P/E Ratio25.76P/E Ratio
PEG21.42PEG
Price to Sales21.12Price to Sales
Price to Book Ratio1.62Price to Book Ratio
Enterprise Value to Revenue11.85
Enterprise Value to EBIT-20.82
Enterprise Value to Net Income-38
Total Debt to Enterprise0.04
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
-$0.93
Est. -$0.66
Revenue
$2.96 M
Est. $9.07 M

Next Earnings Call

Expected Date
March 18, 2027
EPS Estimate
$3.19
Consensus analyst estimate
Revenue Estimate
$43.14 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 67.28%
Total Calls13,700▼ 49.63%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %51.30%▼ 48.30%
Total Invested$226.78M▼ 56.02%
Investors Holding56▼ 41.00%

About Assembly Biosciences Inc

Assembly Biosciences Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 5 open-market insider sales for Assembly Biosciences in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.